Safety Concerns with Testosterone Enanthate and Oxandrolone Use for Cutting
Using testosterone enanthate 250mg/week and oxandrolone 30mg/day for cutting purposes is not safe and poses significant health risks that outweigh any potential benefits.
Testosterone Enanthate Usage Concerns
- The FDA-approved dosage for testosterone enanthate in male hypogonadism is 50-200mg every 2 weeks or 50mg weekly, making 250mg/week significantly higher than therapeutic doses 1
- Testosterone enanthate injections are associated with greater risk of cardiovascular events, hospitalizations, and deaths compared to other testosterone formulations due to fluctuating serum testosterone levels with peaks and valleys 2
- The FDA required labeling changes in 2015 to warn about possible increased risk of heart attack and stroke with testosterone preparations 2
- Supraphysiologic testosterone levels are associated with erythrocytosis (elevated red blood cell count), which increases risk of thrombotic events 2
Oxandrolone Usage Concerns
- Oxandrolone (Oxandrin) is typically prescribed at 2.5-20mg/day for medical conditions, making 30mg/day higher than standard therapeutic doses 2
- As a 17α-alkylated androgen, oxandrolone can cause adverse effects including weight gain, virilization, acne, altered libido, muscle pains, headaches, depression, fatigue, hypertension, and alterations in lipid profile 2
- Oxandrolone can significantly decrease HDL-C (good cholesterol) and increase LDL-C (bad cholesterol), increasing cardiovascular risk 3
Combined Use Risks
- The combination of high-dose testosterone and oxandrolone amplifies risks of:
Monitoring Recommendations (if use continues despite risks)
- Regular blood tests every 2-3 months to monitor:
Alternative Approaches for Cutting
- Focus on lifestyle modifications including caloric deficit through diet and increased physical activity 2
- Consider that weight loss through proper diet and exercise can naturally improve testosterone levels by 1-2 nmol/L 2
- If testosterone therapy is medically indicated, use standard therapeutic doses under medical supervision 1